About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Mbnl2em1.1Coop
endonuclease-mediated mutation 1.1, Thomas A Cooper
MGI:8350478
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Mbnl1em1Coop/Mbnl1em1Coop
Mbnl2em1Coop/Mbnl2em1.1Coop
X/Tg(Myh11-icre/ERT2)1Soff
Not Specified MGI:8350484


Genotype
MGI:8350484
cn1
Allelic
Composition
Mbnl1em1Coop/Mbnl1em1Coop
Mbnl2em1Coop/Mbnl2em1.1Coop
X/Tg(Myh11-icre/ERT2)1Soff
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mbnl1em1Coop mutation (0 available); any Mbnl1 mutation (39 available)
Mbnl2em1.1Coop mutation (0 available); any Mbnl2 mutation (65 available)
Mbnl2em1Coop mutation (0 available); any Mbnl2 mutation (65 available)
Tg(Myh11-icre/ERT2)1Soff mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• intestine of mice treated with tamoxifen between 25 and 40 days of age for a total of 8 days and a minimum of 4-week washout period exhibits thickened smooth muscle layers; an increase in both circular and longitudinal jejunum smooth muscle thickness and in longitudinal colonic muscle thickness are seen
• however, no histopatholgical changes are seen in the intestine, with no infiltration of inflammatory cells or atrophy of villi and cell size in TAM treated mice
• structure of smooth muscle appears normal in TAM treated mice suggesting that hypertrophy is not causative of the muscle thickening and markers of smooth muscle phenotypic modulation do not indicate cell dedifferentiation
• Ccnd1, but not Pcna, is upregulated in TAM treated mice, suggesting that smooth muscle cells may enter but not progress through the cell cycle or could indicate cellular senescence
• whole intestines are shorter in TAM treated mice
• small intestine length is shorter while colon length is unaffected in TAM treated mice
• mice treated with tamoxifen exhibit a delay in both small intestine and colonic transit

growth/size/body
• small weight increase and no change in body length is seen 2 months after TAM treatment

muscle
• intestine of mice treated with tamoxifen between 25 and 40 days of age for a total of 8 days and a minimum of 4-week washout period exhibits thickened smooth muscle layers; an increase in both circular and longitudinal jejunum smooth muscle thickness and in longitudinal colonic muscle thickness are seen
• however, no histopatholgical changes are seen in the intestine, with no infiltration of inflammatory cells or atrophy of villi and cell size in TAM treated mice
• structure of smooth muscle appears normal in TAM treated mice suggesting that hypertrophy is not causative of the muscle thickening and markers of smooth muscle phenotypic modulation do not indicate cell dedifferentiation
• Ccnd1, but not Pcna, is upregulated in TAM treated mice, suggesting that smooth muscle cells may enter but not progress through the cell cycle or could indicate cellular senescence





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/19/2026
MGI 6.24
The Jackson Laboratory